SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001213900-23-022463
Filing Date
2023-03-23
Accepted
2023-03-23 16:49:49
Documents
57
Period of Report
2022-12-31

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT f10k2022_relmadatherap.htm   iXBRL 10-K 985844
2 CONSENT OF MARCUM LLP f10k2022ex23-1_relmadatherap.htm EX-23.1 2404
3 CERTIFICATION f10k2022ex31-1_relmadatherap.htm EX-31.1 7994
4 CERTIFICATION f10k2022ex31-2_relmadatherap.htm EX-31.2 8022
5 CERTIFICATION f10k2022ex32-1_relmadatherap.htm EX-32.1 3735
6 CERTIFICATION f10k2022ex32-2_relmadatherap.htm EX-32.2 3709
  Complete submission text file 0001213900-23-022463.txt   4642960

Data Files

Seq Description Document Type Size
7 XBRL SCHEMA FILE rlmd-20221231.xsd EX-101.SCH 46883
8 XBRL CALCULATION FILE rlmd-20221231_cal.xml EX-101.CAL 24232
9 XBRL DEFINITION FILE rlmd-20221231_def.xml EX-101.DEF 212420
10 XBRL LABEL FILE rlmd-20221231_lab.xml EX-101.LAB 456530
11 XBRL PRESENTATION FILE rlmd-20221231_pre.xml EX-101.PRE 226353
51 EXTRACTED XBRL INSTANCE DOCUMENT f10k2022_relmadatherap_htm.xml XML 395092
Mailing Address 2222 PONCE DE LEON BLVD. 3RD FLOOR CORAL GABLES FL 33134
Business Address 2222 PONCE DE LEON BLVD. 3RD FLOOR CORAL GABLES FL 33134 646 876 3459
RELMADA THERAPEUTICS, INC. (Filer) CIK: 0001553643 (see all company filings)

IRS No.: 455401931 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-39082 | Film No.: 23756841
SIC: 2834 Pharmaceutical Preparations